← back to search

Sami J. Barmada

University of Michigan · US
Area of research
Neurology · Molecular Biology
Research interest
Research interests include Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Genetic Neurodegenerative Diseases, and RNA Research and Splicing.
h-index
42
citations
9,055
works
148
NIH funding
primary concept
email

Recent publications

Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia
Alzheimer s & Dementia 2025cited by 8position: middledoi
Stress granule formation helps to mitigate neurodegeneration
Nucleic Acids Research 2024cited by 28position: middledoi
Ribosomal quality control factors inhibit repeat-associated non-AUG translation from GC-rich repeats
Nucleic Acids Research 2024cited by 19position: middledoi
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration
JAMA Network Open 2024cited by 18position: middledoi
TorsinA is essential for neuronal nuclear pore complex localization and maturation
Nature Cell Biology 2024cited by 17position: middledoi
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
Neurology and Therapy 2023cited by 32position: middledoi
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders
Cell Reports Medicine 2022cited by 69position: middledoi
ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion
Nature Methods 2022cited by 48position: middledoi
Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology
Scientific Reports 2022cited by 38position: middledoi
TDP-43 stabilizes <i>G3BP1</i> mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia
Brain 2021cited by 61position: middledoi
A native function for RAN translation and CGG repeats in regulating fragile X protein synthesis
Nature Neuroscience 2020cited by 77position: middledoi
An Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43 Yields Neuroprotective Properties
ACS Chemical Biology 2020cited by 34position: middledoi
Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS
Journal of Clinical Investigation 2019cited by 138position: lastdoi
Overexpression of the essential Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis
PLoS Genetics 2017cited by 63position: middledoi
Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1
Proceedings of the National Academy of Sciences 2015cited by 133position: firstdoi
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
Nature Chemical Biology 2014cited by 425position: firstdoi
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects
Journal of Clinical Investigation 2014cited by 269position: middledoi
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy
Proceedings of the National Academy of Sciences 2013cited by 352position: middledoi
Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration
Nature Chemical Biology 2013cited by 180position: middledoi
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability
Proceedings of the National Academy of Sciences 2012cited by 336position: middledoi
Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury
Journal of Clinical Investigation 2012cited by 317position: middledoi
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models
Nature Genetics 2012cited by 257position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Steven Finkbeiner · Gladstone Institutes8 papers (2012–2015)Elizabeth M.H. Tank · University of Michigan–Ann Arbor5 papers (2015–2024)Xingli Li · University of Michigan–Ann Arbor4 papers (2014–2024)Andrea Serio · King's College London4 papers (2012–2019)Nicolás Gómez · Tufts University4 papers (2019–2024)James Shorter · University of Bonn3 papers (2012–2022)Bilada Bilican · University of Edinburgh3 papers (2012–2014)Peter K. Todd · Centre for Human Genetics3 papers (2020–2024)Eric J. Huang · University of California, San Francisco3 papers (2012–2015)D. Michael Ando · Google (United States)3 papers (2013–2014)Christopher E. Shaw · University of Auckland3 papers (2012–2014)Siddharthan Chandran · Edinburgh Royal Infirmary3 papers (2012–2014)Agnes L. Nishimura · Queen Mary University of London2 papers (2012–2013)Liberty François‐Moutal · University of Arizona2 papers (2020–2022)Amy Krans · University of Michigan–Ann Arbor2 papers (2020–2024)Jacob M. Carlson · University of Arizona2 papers (2020–2022)Robert V. Farese · Memorial Sloan Kettering Cancer Center2 papers (2012–2012)Mónica A. Carrasco · Columbia University2 papers (2012–2013)Tom Maniatis · Allen Institute for Brain Science2 papers (2012–2013)Ian Wilmut · University of Edinburgh2 papers (2012–2013)